China’s medical big data company Medbanks raised ¥1 billion in a series D round funding led by Tencent and followed by Wu Capital, Eight Roads of Fidelity Investment Group, F-Prime Capital, CLP Zhongjin, and IDG.
Established in 2014, Medbacks targets tumor diseases to provide an eco-platform for clinical medicine of tumor and professional medical services. It has four main businesses including SMO, RWE and patient management, DTP, and PPO.
South Africa Today